BTG Pactual Asset Management US’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-63,500
Closed -$5.54M 296
2025
Q2
$5.54M Buy
+63,500
New +$5.39M 0.61% 46

Other funds holding MDT

BTG Pactual Asset Management US's MDT Position: Q1 2026 in Review

BTG Pactual Asset Management US sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,027 shares — an estimated $291K sold.

BTG Pactual Asset Management US first reported a position in MDT in Q4 2025 and held it in 1 quarter. The position peaked at $291K in Q4 2025. 2,232 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • BTG Pactual Asset Management US reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • BTG Pactual Asset Management US sold 3,027 Medtronic shares in Q1 2026, an estimated $291K.
  • BTG Pactual Asset Management US first reported a position in Medtronic in Q4 2025 and held it in 1 quarter.
  • BTG Pactual Asset Management US's Medtronic position peaked at $291K in Q4 2025.
  • 2,232 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q1 2026, filed 14 May 2026.